Software Validation Medical Device: Compliance and Tool Selection Guide | Valkit.ai
Software Validation Medical Device: Compliance and Tool Selection Guide
Master software validation medical device compliance with this guide on regulations, risk-based validation, and automated tools.
Steve Ferrell·
Why Software Validation for Medical Devices Is a Regulatory Non-Negotiable
Software validation in medical devices is the process of confirming — through documented, objective evidence — that your software does exactly what it's supposed to do for its intended use. Whether you're building a device that runs on software or using software to build a device, regulators expect proof.
Here's what you need to know at a glance:
Question Quick Answer What is it? Documented confirmation that software meets user needs and intended use Who requires it? FDA (21 CFR Part 820), ISO 13485, EU MDR, IEC 62304 What software needs it? Device software, QMS tools, production software, OTS and SaaS tools What's the risk of skipping it? FDA warning letters, device recalls, patient safety failures What's the modern approach? Risk-based Computer Software Assurance (CSA) with automated tooling
The stakes are real. Between 1992 and 1998, 242 out of 3,140 medical device recalls — nearly 8% — were directly caused by software failures. More striking: 79% of those software recalls were triggered by defects introduced after the software was already released, during updates and changes. That statistic alone explains why regulators treat software validation as a continuous lifecycle requirement, not a one-time checkbox.
And the compliance pressure hasn't eased. In 2022, the FDA issued 538 warning letters to medical device companies. Roughly 20% cited process validation failures, and 3% were specifically for software tool validation deficiencies.
For validation managers, this creates a relentless operational challenge: keeping pace with regulatory expectations while managing lean teams, long timelines, and software environments — especially cloud tools — that change constantly.
I'm Stephen Ferrell, Chief Product Officer at Valkit.ai, and over more than two decades in IT governance, computerized system validation, and GxP quality systems, I've guided hundreds of organizations through the exact software validation medical device compliance challenges this guide addresses. As a contributing author to ISPE GAMP 5 Second Edition and chair of GAMP Americas, I've seen where validation programs succeed — and where they break down under real-world pressure.
Steve Ferrell
Chief Product Officer
Regulatory Framework for Software Validation Medical Device
Navigating the regulatory landscape for medical devices can feel like trying to assemble flat-pack furniture without the manual. But when it comes to software, the rules are clear, and the consequences of ignoring them are severe.
The regulatory framework for software validation has undergone massive harmonization. On February 2, 2024, the FDA published the Quality Management System Regulation (QMSR) final rule, which officially took effect on February 2, 2026. This landmark update aligned the FDA’s 21 CFR Part 820 Quality System Regulation directly with the international standard ISO 13485:2016.
If your organization is looking to establish a robust compliance foundation, the starting point is understanding how these regulations intersect. Under 21 CFR 820.70(i), any software used to automate device production processes or any part of the quality system must be validated for its intended use.
For a comprehensive look at how these rules apply to physical and digital systems, check out our guide on medical device validation.
Software Verification vs. Software Validation
In quality assurance, "verification" and "validation" are often used interchangeably over coffee, but they mean entirely different things to an auditor.
Software Verification asks: "Are we building the product right?" It is the process of confirming that the design outputs of a specific phase meet the specified requirements for that phase. This involves code inspections, static analysis, unit testing, and integration testing.
Software Validation asks: "Are we building the right product?" It confirms by examination and objective evidence that the final software specifications conform to user needs and its intended use.
Verification is about engineering precision; validation is about clinical and operational utility. Under design controls (21 CFR 820.30(g)), validation must be performed under actual or simulated use conditions, using representative end-users. It goes beyond functional checks to ensure the software performs safely in its real-world environment.
Dimension Software Verification Software Validation Core Question Are we building the product right? Are we building the right product? Focus Compliance with technical specifications and design inputs. Compliance with user needs, safety requirements, and intended use. Activities Code reviews, unit testing, static analysis, integration testing. Clinical trials, usability testing, black-box testing, simulated use. Execution Done continuously throughout development phases. Done on the final software build under real or simulated conditions.
Global Standards: FDA, ISO 13485, and IEC 62304
If you are marketing medical devices globally, you must align your software lifecycle with three major standards:
IEC 62304: This is the international benchmark for medical device software lifecycle processes. It classifies software into three safety classes based on the potential severity of harm to the patient:
Class A: No injury or damage to health is possible.
Class B: Non-serious injury is possible.
Class C: Death or serious injury is possible.
ISO 13485 (Clause 4.1.6): This clause mandates that organizations document procedures for validating any computer software used in the quality management system (QMS) prior to its initial use.
EU MDR (Annex I, Section 17.2): For the European market, software must be developed and validated taking into account the entire lifecycle, risk management, and usability.
Not all software used in a medical device company is created equal. You wouldn't validate a complex AI-driven diagnostic tool the same way you validate a spreadsheet used to log office temperatures. Understanding how to categorize your software is the first step in scoping your validation efforts.
A critical part of this process is establishing a comprehensive software inventory. For every software tool used, you must document its intended use. The scope of your validation is determined by how that intended use impacts patient safety, product quality, and record integrity.
To help structure this categorization, many manufacturers turn to the ISPE GAMP 5 framework. You can read more about how to apply these categories in our guide on gamp 5 software categories.
Software in the Device (SiMD) vs. Software as a Medical Device (SaMD)
Software directly associated with a medical device generally falls into one of two categories:
Software in a Medical Device (SiMD): This is embedded software or firmware that is part of the physical medical device. Examples include the software that controls an infusion pump's motor or the firmware in a pacemaker.
Software as a Medical Device (SaMD): This is standalone software that performs medical purposes without being part of a hardware medical device. Examples include mobile apps that analyze ECG data to detect arrhythmias or cloud-based AI algorithms that identify diabetic retinopathy from retinal scans.
For SaMD, risk categorization is often guided by the International Medical Device Regulators Forum (IMDRF) framework, which looks at the state of the patient's healthcare situation (critical, serious, or non-serious) and the significance of the information provided by the software (treat/diagnose, drive clinical management, or inform clinical management).
Additionally, modern cybersecurity requirements (such as the FDA's 2023 Cybersecurity Guidance) require manufacturers to validate software integrity and provide a Software Bill of Materials (SBOM) to ensure vulnerability tracking throughout the lifecycle.
Production, QMS, and Off-the-Shelf (OTS) Software
Beyond product software, manufacturers must validate the digital tools used to run their businesses. This category includes:
Production Software: Software used to automate manufacturing processes, such as Programmable Logic Controllers (PLCs) on an assembly line.
Quality System Software: Tools used to manage quality records, such as document management systems, training logs, and complaint tracking software.
Off-the-Shelf (OTS) Software: Third-party applications (like spreadsheets or databases) used to support regulated activities.
For instance, if a team uses a standard spreadsheet to record curing readings, it represents a low-risk activity requiring basic verification. However, if they add custom formulas to automatically calculate process performance statistics, the risk increases, and formal validation is required.
Risk-Based Validation: CSV vs. Computer Software Assurance (CSA)
Historically, Computer System Validation (CSV) has been notoriously paper-heavy. Quality teams often spent 80% of their time writing documentation and only 20% actually testing the software.
CSA shifts the focus back to where it belongs: patient safety, product quality, and software integrity. Instead of testing every single button and menu option with equal vigor, CSA encourages manufacturers to focus their testing efforts on high-risk features that directly impact the device or quality records, while leveraging vendor testing for low-risk, standard functionalities.
For a strategic look at implementing this modern paradigm, explore our guide on the csv risk based approach.
Determining the Level of Effort and Scope
How do you decide how much validation is "enough"? It starts with a formal risk assessment under ISO 14971.
Manufacturers must evaluate the software's risk level. The FDA’s modern pre-market submission guidelines categorize software documentation into two levels:
Basic: Required for software where a failure is unlikely to cause serious harm.
Enhanced: Required for software where a failure could present a high risk of death or serious injury (such as Class III devices or complex diagnostic AI).
When evaluating electronic systems that store quality records, you must also ensure compliance with the 21 cfr part 11 validation requirements to secure electronic records and signatures.
The Software Validation Lifecycle and Deliverables
To execute validation successfully, you must follow a structured lifecycle that generates clear, audit-ready objective evidence.
Many medical device companies utilize the traditional 4Q model (Design, Installation, Operational, and Performance Qualification) or a GAMP-aligned V-model to map software requirements to their corresponding testing phases. To understand how to structure this lifecycle, you can refer to our detailed walk-through of the computer system validation process.
Key Steps in the Software Validation Medical Device Process
A compliant software validation medical device process typically follows these five core steps:
Software Validation Plan (SVP): Defines the system scope, responsibilities, validation environment, and acceptance criteria.
System Requirements Specification (SRS): Clearly documents what the software needs to do, including functional, security, and performance requirements.
Validation Protocol & Test Specifications: Outlines the testing scenarios, including boundary cases and error handling.
IQ/OQ/PQ Execution:
Installation Qualification (IQ): Verifies the software is installed correctly in the target environment.
Operational Qualification (OQ): Verifies the software functions as expected across its operating limits.
Performance Qualification (PQ): Verifies the software performs reliably under actual clinical or production workloads.
Final Validation Report: Summarizes the testing results, documents any deviations, and provides a formal release statement.
Your final validation package should contain these essential deliverables:
Software Validation Plan
System Requirements Specification (SRS)
Software Risk Assessment (ISO 14971)
Traceability Matrix (linking requirements to tests)
IQ/OQ/PQ Protocols and executed test records
Software Bill of Materials (SBOM)
Final Validation Report
Compiling Objective Evidence and Vendor Packages
Objective evidence is the cornerstone of validation. If it isn't documented, an auditor assumes it didn't happen. This evidence typically includes signed test execution logs, automated test outputs, and screenshots of critical steps.
Many software vendors now offer "pre-validated" software packages. While these packages are highly valuable, the FDA is clear: you cannot blindly accept a vendor’s pre-validation package without in-house verification.
Manufacturers must still perform a vendor audit or assessment to evaluate the quality of the developer's processes, and then execute a portion of the testing in-house to confirm the software works as intended within their unique operating environment.
Managing Cloud-Based SaaS Tools and Revalidation
The rise of Software-as-a-Service (SaaS) and cloud computing has transformed how medical device companies operate. However, these dynamic environments present a unique compliance challenge.
Unlike traditional on-premise software, where you control when and how updates are installed, cloud vendors deploy continuous updates and security patches automatically. Under international guidelines like the annex 11 eu guide 2026, manufacturers must maintain control over their validated state, even when the software resides in the cloud.
The Challenge of Continuous SaaS Updates
When a cloud provider pushes an update, they can instantly invalidate your previous manual validation efforts. If a manual validation of a cloud tool takes your team two weeks to execute, and the vendor updates the tool every month, you are caught in an endless, unsustainable cycle of paperwork.
To survive in a SaaS-dominated world, quality teams must transition to automated validation. By scheduling automated integrity checks (for example, running every 7 days), you can continuously verify system performance, capture automated screenshots, and generate compliant documentation without manual intervention.
When and How to Perform Revalidation
Revalidation is not only triggered by automated vendor updates. It is required whenever there are:
Post-production software changes or custom code updates.
Upgrades to the underlying operating system or hardware infrastructure.
Changes in the software’s intended use (e.g., using a tool for a new clinical application).
Remember the recall statistics: 79% of software-related recalls are caused by bugs introduced during post-production changes. This is why a structured impact assessment must be performed before any change is pushed to production. If the change impacts a high-risk feature, targeted revalidation must be executed to ensure no new defects have been introduced.
Compliance Pitfalls and Automated Validation Solutions
Failing to maintain a validated state can lead to severe regulatory consequences. FDA warning letters (483s) frequently cite software validation deficiencies, ranging from a complete lack of process validation to inadequate testing of quality system tools.
To avoid these costly disruptions, many forward-thinking life sciences companies are moving away from paper-based, manual testing and adopting an automated compliance platform.
Common Pitfalls in Software Validation Medical Device Compliance
When analyzing FDA warning letters, three common software validation deficiencies stand out:
Inadequate Risk Analysis: Failing to link validation testing to a formal risk assessment. Companies often spend days testing low-risk features while leaving critical, high-risk functions unverified.
Over-Reliance on Vendor Testing: Assuming a "Part 11 compliant" certificate from a vendor is enough. Regulators require proof of validation for your specific intended use.
Lack of Traceability: Failing to maintain a Requirements Traceability Matrix (RTM). If you cannot prove that every system requirement has a corresponding test case and test result, your validation is incomplete.
Transitioning to Automated Validation Tools
Traditional validation is slow, error-prone, and expensive. Transitioning to automated validation tools allows medical device manufacturers to maintain continuous compliance in dynamic cloud environments.
At Valkit.ai, our digital validation platform is designed specifically to solve these challenges. By using smart automation, cloning, and compliance tools, we help pharmaceutical, biotech, and medical device companies reduce their validation costs by up to 80% and shrink validation timelines from weeks to hours.
With automated test execution and real-time electronic signatures, you can ensure your systems are always inspection-ready, without burying your quality team in paperwork.
Frequently Asked Questions about Software Validation
What is the difference between software verification and validation?
Verification confirms that the software meets its technical specifications ("Are we building the product right?"), while validation confirms that the software meets the user's actual needs and its intended use in a clinical or operational setting ("Are we building the right product?").
Does off-the-shelf (OTS) software require validation?
Yes. If OTS software (like a spreadsheet or database) is used in device production or within the quality management system, the manufacturer is responsible for validating it for its specific intended use.
How often should cloud-based QMS software be revalidated?
Revalidation frequency should be risk-based. While major updates require an immediate impact assessment and targeted testing, implementing automated weekly validation checks is the most effective way to maintain continuous compliance for SaaS tools.
Conclusion
In the medical device industry, software validation is not a one-time regulatory hurdle — it is a continuous, lifecycle-long commitment to patient safety and product quality. As software systems grow more complex and cloud-based SaaS tools become the norm, traditional, paper-heavy validation methods simply cannot keep pace.
By embracing a risk-based approach, leveraging modern Computer Software Assurance (CSA) principles, and transitioning to automated validation, manufacturers can protect patient safety while dramatically accelerating their time-to-market.
Ready to leave manual validation paperwork behind? Discover how Valkit.ai's digital validation platform can streamline your compliance workflow, reduce costs by up to 80%, and keep your systems audit-ready in hours instead of weeks. Reach out to our teams in Scotland and Indiana today to schedule a demo.
